Filter
736
Text search:
rifampicin
Featured
112
210
Language
Document type
462
119
78
27
15
14
11
4
3
1
1
1
Countries
52
50
29
28
18
17
14
13
13
13
13
12
11
11
11
9
9
8
8
7
7
5
5
5
5
5
4
4
4
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
272
95
18
16
14
12
9
Toolboxes
344
54
35
27
25
14
10
6
5
4
4
4
2
1
1
1
1
Annual Report: 2015-2016
UGANDA NATIONAL TUBERCULOSIS AND LEPROSY CONTROL PROGRAMME
Guidelines for treatment of drug-susceptible tuberculosis and patient care
2017 update
Guidelines for treatment of drug-susceptible tuberculosis and patient care
Update 2017
National Tuberculosis and Leprosy Conrol Programme
Policy framework.
Expert opinion of the European Tuberculosis Laboratory Initiative core group members for the WHO European Region.
Lignes directrices.
Collection Avis et Rapports.
Information für Ärzte.
MMWR: Recommendations and Reports / Vol. 62 / No. 9
Morbidity and Mortality Weekly Report
October 25, 2013
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention.
Division of Tuberculosis Elimination.
5th revised edition.
This document provides a ranking of medically important antimicrobials for risk management of antimicrobial resistance due to non-human use. The current revision took place at the seventh meeting of the AGISAR held in Raleigh, United States of America in 2016.
Ensuring Access to Simple, Safe and Effective First-Line Medicines for Tuberculosis.
Accessed in November 2017.
